Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount of radiation treatment received to healthy tissue


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00593840
Study type Interventional
Source Washington University School of Medicine
Contact
Status Active, not recruiting
Phase Phase 2
Start date April 11, 2007
Completion date April 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT00117572 - Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Phase 3
Not yet recruiting NCT01607138 - Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life N/A
Recruiting NCT00970502 - Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer Phase 1/Phase 2
Completed NCT00462735 - Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Phase 2